Teckro
Teckro, a healthcare software provider, revolutionizes clinical research for quicker drug development.
Founded
2015Teckro, a healthcare software provider, revolutionizes clinical research for quicker drug development.
Teckro, founded to revolutionize clinical research, focuses on transforming the processes and technologies used in clinical trials. Their core mission is to make all relevant information instantly accessible to every active member of a clinical trial, thereby enhancing connectivity and efficiency among study teams. Teckro offers a modern, data-led software solution that improves site engagement and accelerates the development of drugs and treatments. Their market focus is on life sciences, specifically targeting clinical research organizations and pharmaceutical companies.
Notable affiliated individuals include industry experts and seasoned professionals in clinical research and technology. Teckro has garnered significant investment from prominent venture capital firms, underscoring its potential and credibility in the healthcare technology sector. Key achievements include widespread adoption of their platform by global study teams, which has measurably enhanced site engagement and expedited trial progress. Overall, Teckro's impact lies in its ability to streamline clinical trials, ultimately contributing to quicker drug development and improved patient outcomes.
Companies similar to Teckro include Clinical.ly, TrialSpark, Clinetic and Clinical Research IO.
Teckro was founded in 2015.
Teckro's headquarters is located in New York City, NY, US.
Teckro's most recent funding round was for $25M (USD) in November 2021.
As of Nov 24, 2021, Teckro has disclosed funding of $66M (USD). Undisclosed round amounts are excluded.
Teckro has 75 employees as of Feb 5, 2024.
Clinical Research IO
